With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

With that as the backdrop, here's a closer look at three names that could be worth more than Berkshire Hathaway just five ...

The company sells tirzepatide, approved for weight loss under the name ... Morgan Stanley Research predicts the obesity drug ...

Driven by the growing use of Indic languages for digital content, the internet user base in India is set to surpass 900 million by 2025, driven by the growing use of Indic languages for digital ...

Projections suggest a significant surge, with an expected market value exceeding USD 44.9 billion by 2034, propelled by a robust Compound Annual Growth Rate (CAGR) of 5%. This impressive trajectory is ...

Kansas sports wagers surpass $2.5 billion in 2024 16th January 2025 10:45 am Kansas’ sports wagers grew by 2 per cent to $2.55 billion in 2024, even though the year ended with minimal growth in ...

Prostate cancers are now the third leading cause of cancer deaths in the U.S. The 5-year survival rate is still just 8% for 9-in-10 people, despite substantial efforts to advance treatment.

Mounjaro is the brand name for tirzepatide, and research shows that people with overweight and obesity have lost up to 25% of their body weight on this medication. Social media users have latched onto ...

Los Angeles Police Department Chief Jim McDonnell said officers responded at 5:15 p.m. Tuesday to Glenoaks and Van Nuys boulevards, where a resident had detained a suspect who allegedly set fire ...

Under SEC rules, investors must report within 10 days when their holdings in a company surpass 5% – the SEC’s filing says Mr Musk did not report until 21 days after going beyond that threshold.